Every now and then, a government agency becomes more than a government agency. It becomes a symbol, a debate stage, a budget line with a philosophy problem. The National Center for Complementary and Alternative Medicine, better known as NCCAM, was one of those rare bureaucratic creatures. It lived inside the National Institutes of Health, wore the respectable lab coat of federal science, and asked a question that sounded reasonable on the surface: Can complementary and alternative medicine be tested scientifically?
That question is not foolish. People use herbs, supplements, acupuncture, meditation, massage, chiropractic care, special diets, and every “ancient secret” that ever survived long enough to get a website. When millions of Americans spend money on health approaches outside standard medicine, research matters. Safety matters. Evidence matters. The trouble begins when the category itself becomes slippery. If a treatment works reliably, it eventually stops being “alternative” and becomes medicine. If it does not work, it remains alternative, usually with better branding and a calmer font.
That is why critics have called NCCAM “not even wrong.” The phrase, often used in science criticism, describes claims that are so poorly framed, unfalsifiable, or conceptually confused that they cannot even rise to the level of being wrong in a useful way. A wrong hypothesis can teach us something. A vague one can absorb data like a sponge absorbs spilled coffee: messily, permanently, and without apologizing.
What Was NCCAM?
NCCAM was the former name of what is now the National Center for Complementary and Integrative Health, or NCCIH. Its roots go back to the Office of Alternative Medicine, established in the early 1990s. The center later became NCCAM and, in December 2014, was renamed NCCIH. That name change was more than cosmetic. “Alternative medicine” had become a loaded term. “Integrative health” sounded warmer, more modern, and less likely to make a biostatistician reach for antacids.
The center’s stated purpose was to explore complementary health approaches using rigorous science, train researchers, and provide public information. In principle, that mission is defensible. If people are using a supplement that interacts with blood thinners, someone should study it. If massage helps certain pain conditions, patients deserve honest data. If an herb is useless or dangerous, the public should know before buying a 90-capsule bottle with a leaf on the label.
The controversy was not simply that NCCAM studied unusual topics. Science has always investigated strange claims. The controversy was that NCCAM appeared, to many critics, to give institutional dignity to ideas that had weak plausibility before the first grant dollar was spent. Studying a plant compound with measurable pharmacology is one thing. Funding research around distant healing, energy fields, or implausible cancer regimens is quite another. One is science with muddy boots. The other is fog with a purchase order.
Complementary, Alternative, and Integrative: The Vocabulary Fog Machine
NCCIH defines a non-mainstream practice used alongside conventional medicine as “complementary.” A non-mainstream practice used instead of conventional care is “alternative.” “Integrative” generally refers to coordinated care that combines conventional treatment with complementary approaches that are considered safe and potentially useful.
Those definitions sound tidy until they meet the real world. Yoga for flexibility is not the same kind of claim as homeopathy for infection. Meditation for stress is not the same kind of claim as coffee enemas for pancreatic cancer. A patient using massage during cancer treatment for comfort is not doing the same thing as a patient refusing chemotherapy for an unproven protocol. Yet all these ideas can end up orbiting the same giant umbrella of complementary and alternative medicine.
That umbrella problem is central to the “not-even-wrong” critique. A category that includes relaxation, exercise, botanical chemistry, magical thinking, nutrition, spinal manipulation, prayer, and pseudoscientific energy claims is not a coherent scientific field. It is a junk drawer. Some items are useful. Some are harmless but overhyped. Some are sharp enough to cut you. And somewhere in the back is a mystery key that opens nothing.
The Core Criticism: Why Test What Has No Plausible Mechanism?
Evidence-based medicine does not require that every new idea be perfectly understood before testing. Aspirin was used before its mechanisms were fully mapped. Anesthesia worked before medicine understood everything about consciousness. But there is a difference between an incomplete mechanism and a claim that contradicts established chemistry, physics, or biology.
Critics argued that NCCAM too often treated low-plausibility claims as if they merely lacked data. That distinction matters. A poorly studied antibiotic candidate may be unknown. A sugar pill diluted past the point where active molecules remain is not merely unknown in the same way. A botanical extract may contain active compounds. A claim about invisible healing energy that cannot be measured, standardized, or meaningfully blinded sits in a different scientific zip code.
When research begins with “maybe this impossible-sounding thing works anyway,” the burden of proof should be extremely high. Instead, alternative medicine often benefits from a softer standard. Small studies, subjective endpoints, weak controls, and post-hoc explanations become marketing fuel. Negative trials are dismissed because the wrong dose, wrong practitioner, wrong moon phase, or insufficiently open mind supposedly spoiled the effect.
Major NCCAM-Era Lessons From Clinical Trials
St. John’s Wort and Depression
St. John’s wort is one of the more biologically plausible alternative remedies because it contains active compounds and can interact with medications. That also means it is not “just natural” in the harmless-tea sense. NCCIH and the National Institute of Mental Health supported studies that found St. John’s wort was no more effective than placebo for major depression of moderate severity. The lesson was not that all botanical research is silly. The lesson was that popularity is not proof, and “natural” does not mean clinically reliable.
Echinacea and the Common Cold
Echinacea became a medicine-cabinet celebrity for people trying to dodge colds. It had the perfect supplement résumé: plant-based, familiar, and sold with the confidence of a product that knows you are tired of sneezing. But rigorous studies, including a major trial published in The New England Journal of Medicine, found no clinically significant effects from tested Echinacea angustifolia extracts on infection rates or symptom severity. The common cold, as usual, remained unimpressed.
Ginkgo Biloba and Dementia Prevention
Ginkgo biloba was promoted for memory and cognitive health, especially among older adults. A large randomized trial found that ginkgo did not reduce the overall incidence of dementia or Alzheimer’s disease in elderly participants. This is exactly the kind of result public research should clarify: if a widely used supplement does not prevent a feared disease, consumers deserve to know before spending money for years.
Glucosamine, Chondroitin, and Arthritis Pain
Glucosamine and chondroitin are more complicated. The NIH-supported GAIT trial produced mixed results, with no broad, dramatic benefit for most knee osteoarthritis patients, though some subgroup signals kept the discussion alive. This is where nuance matters. Not every complementary therapy falls into the same bucket. Some produce mixed evidence, some modest benefits, some no benefit, and some are implausible from the start. The problem with NCCAM was that the brand umbrella made these differences harder for the public to see.
The Budget Question: Small by NIH Standards, Large by Common Sense
NCCIH’s recent appropriations have been around the hundreds of millions of dollars, with FY 2024 listed at $170.3 million. In the vast NIH universe, that is not the biggest planet. But to ordinary taxpayers, $170 million is not “loose change.” It is enough money to fund serious research, training, public health surveillance, and clinical trials that answer practical questions.
Supporters argue that the spending is justified because Americans use complementary health approaches and deserve evidence. That argument has weight. NCCIH and CDC-related analyses have estimated tens of billions in annual out-of-pocket spending on complementary approaches. Pain management use has also grown over time, especially for practices such as yoga, meditation, massage, and chiropractic care.
Critics respond that consumer popularity is not enough to justify a dedicated center built around a medically incoherent category. Americans also spend money on fad diets, detox teas, and miracle hair gadgets that look like rejected kitchen utensils. Popularity can justify consumer protection, safety research, and public education. It does not automatically justify treating “alternative medicine” as a distinct scientific domain.
What NCCAM Got Right
A fair critique should admit that NCCAM and NCCIH have done some useful work. Public-facing safety information about supplements is valuable. Research on pain, stress, behavior, sleep, exercise, and mind-body practices can be legitimate when framed properly. Studying how patients use non-mainstream approaches can help clinicians ask better questions and prevent dangerous interactions.
The FDA does not approve dietary supplements for safety and effectiveness before they are marketed. That regulatory reality makes independent information essential. Supplements can interact with medications, create surgical risks, or expose consumers to contamination and misleading claims. If NCCIH helps people understand those risks, that is public health, not woo.
The center also helped produce negative results. Negative results are not failure in science. They are part of science doing its job. The failure comes when negative results do not change public claims, marketing behavior, or institutional enthusiasm. If a therapy fails in a rigorous trial and still gets advertised as “clinically inspired,” the problem is not the p-value. The problem is the ecosystem.
What NCCAM Got Wrong
NCCAM’s deepest flaw was conceptual. It began with a cultural category, not a scientific one. “Alternative medicine” is defined largely by what it is not: not standard care, not mainstream, not fully accepted. That makes it unstable. Once evidence supports an approach, the approach can migrate into conventional care. Once evidence fails, advocates may argue that conventional trials cannot capture its special magic. Heads, alternative medicine wins. Tails, science was too narrow.
This creates an asymmetry. Conventional medicine is expected to discard treatments that fail. Alternative medicine often rebrands them. “Alternative” becomes “complementary.” “Complementary” becomes “integrative.” “Energy healing” becomes “biofield.” The vocabulary evolves faster than the evidence. It is like watching a raccoon escape a trash can while wearing a tiny lab coat.
Another mistake was the endorsement effect. When NIH studies a claim, the public may interpret that as “there must be something to it.” A grant does not equal validation, but nuance rarely survives a supplement label. For questionable therapies, federal attention can become marketing oxygen. Even when the study is negative, the promotional phrase “studied by the NIH” may live forever.
The “Not-Even-Wrong” Problem in Plain English
A claim is scientifically useful when it can be tested in a way that risks proving it false. “This compound lowers blood pressure by a measurable amount compared with placebo” is testable. “This healing practice balances energy and supports wellness” may be emotionally appealing, but it is often too vague to fail. If every outcome can be explained away, the claim is not sturdy enough for science. It is a motivational poster wearing a stethoscope.
That is the heart of the NCCAM controversy. The center tried to bring rigorous science to a marketplace that often thrives on ambiguity. But rigorous science and ambiguity are not equal dance partners. One asks for controls, blinding, replication, mechanisms, effect sizes, adverse events, and clinical relevance. The other says, “Wellness is a journey.” Lovely. So is a road trip, but you still need a map.
Why This Still Matters Under NCCIH
NCCAM is gone in name, but the debate continues under NCCIH. The newer language emphasizes complementary and integrative health, whole person health, pain management, prevention, and wellness. Some of that shift is sensible. Chronic pain, stress, sleep, movement, and behavior are real medical concerns. Patients want options beyond pills and procedures, and clinicians need evidence-based ways to support them.
Still, the same caution applies. “Whole person health” should not become a velvet rope that lets weak claims enter through the side door. Integrative care is valuable only when the integrated parts are safe, evidence-based, and honestly described. Combining good medicine with bad medicine does not create holistic medicine. It creates good medicine with a hitchhiker.
How Readers Should Think About Complementary Health Claims
The best approach is neither automatic rejection nor wide-eyed acceptance. Ask practical questions. What exactly is being claimed? Has it been tested against placebo or standard care? Are the outcomes objective or subjective? How large is the benefit? What are the risks? Could it delay effective treatment? Is the product regulated like a drug or sold as a supplement? Who profits if you believe the claim?
A complementary approach can be reasonable when it improves comfort, mobility, stress, or quality of life without replacing necessary medical care. Meditation, gentle movement, massage, and certain behavioral approaches may help some people with symptom management. But no amount of soothing language should turn weak evidence into strong evidence. A candlelit room does not improve study design.
Experiences and Practical Reflections: Living With the NCCAM Debate
One of the most common experiences in discussions about NCCAM is the awkward dinner-table moment. Someone says an herb “boosted” their immune system, a bracelet “balanced” their energy, or a detox program “reset” their body. Nobody wants to be rude. Nobody wants to become the person who brings randomized controlled trials to dessert. But health claims matter because people act on them. They spend money, delay appointments, stop medications, or mix supplements with prescriptions without telling their doctor.
A practical lesson from the NCCAM story is that personal experience is powerful but unreliable. If you take a supplement and feel better three days later, the improvement may be real. The cause may not be. Symptoms naturally rise and fall. Colds end. Pain fluctuates. Depression has better and worse weeks. The body heals many things while we are busy giving credit to the last pill, tea, oil, adjustment, or ritual we tried. Human pattern recognition is magnificent, but it also sees faces in toast.
Another experience is watching language soften skepticism. A claim that once sounded extreme becomes easier to accept when wrapped in words like “natural,” “ancient,” “gentle,” “holistic,” and “supportive.” These words are not evidence. They are mood lighting. A natural product can be useful, useless, or dangerous. Ancient practices can contain wisdom, error, or both. A gentle therapy can still mislead if it persuades someone to ignore effective care.
Clinicians often experience the NCCAM problem from the other side. Patients may use supplements or alternative therapies but hesitate to mention them because they fear being judged. That silence can be risky. St. John’s wort, for example, can interact with important medications. Other supplements may affect bleeding risk, blood sugar, blood pressure, sedation, or surgery planning. A good doctor does not need to mock a patient’s choices. A good doctor needs complete information.
Writers, editors, and health publishers face their own challenge. Alternative medicine headlines are easy traffic. “This ancient remedy may help…” is more clickable than “Evidence remains limited and context-dependent.” But responsible health content should not turn uncertainty into hype. The NCCAM story reminds publishers to separate curiosity from endorsement. It is fine to say researchers studied something. It is not fine to imply that being studied makes it proven.
The healthiest personal takeaway is simple: stay curious, but keep your standards. Try low-risk comfort measures if they do not replace real care. Tell your healthcare provider what you use. Be suspicious of miracle claims, especially for cancer, heart disease, infections, autism, dementia, or chronic pain. Respect evidence more than branding. And remember that science is not close-minded because it asks for proof. It is doing the job we desperately need it to do.
Conclusion
NCCAM was not wrong because it asked whether popular health practices deserve scientific attention. That question is valid. NCCAM became “not even wrong” when the category of alternative medicine blurred the line between plausible research, patient comfort, supplement safety, placebo effects, and claims that were never scientifically sturdy in the first place.
The renamed NCCIH has an opportunity to do better by focusing on rigorous evidence, patient safety, transparent communication, and practical symptom management without giving weak claims a federal halo. The public deserves research that clarifies, not research that accidentally advertises. The future of integrative health should be simple: keep what works, study what is plausible, warn about what is risky, and let unsupported claims retire gracefully. Preferably before they get a rebrand.
